Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bruker Opens New Preclinical Imaging Center of Excellence for the Americas

Published: Thursday, January 30, 2014
Last Updated: Thursday, January 30, 2014
Bookmark and Share
Massachusetts Center will provide advanced development, demonstration and customer support capabilities for Bracer’s unique multimodal preclinical imaging systems portfolio.

Bruker has announced the official opening of a new Preclinical Imaging Center of Excellence for the Americas in Billerica, Massachusetts. The facility offers advanced development, demonstration and support facilities for Bruker’s industry-leading portfolio of preclinical imaging instrumentation and multimodal platforms.

In showcasing both the individual imaging technologies and the benefits gained from combining multimodal experiments, the Center will play a key role in promoting the successful application of complementary imaging information in preclinical research in oncology, cardiology, inflammation, musculoskeletal imaging and the neurosciences.

Bruker customers will participate in an opening symposium for the new center, with many New England research institutions and pharmaceutical companies present. Speakers from Bruker’s management will be joined by Srinivasan Mukundan Jr., MD/PhD, Chief of Neuroradiology at Brigham and Women’s Hospital in Boston, who will highlight the importance of cutting-edge technology innovation for preclinical imaging research, while adding translational perspectives from the clinic. The event will allow members of the preclinical imaging community to interact with the Bruker imaging instruments, all running live in the lab.

“I am really excited to see the establishment of a full-featured, preclinical imaging laboratory in the Boston area,” said Frederic Fahey, DSc, Director of Nuclear Medicine Physics at Boston Children's Hospital. “We look forward to the development of many new collaborations and innovations as a result of this endeavor by Bruker.”

The new Bruker Center of Excellence represents a significant global infrastructure expansion for all technical R&D, support and demonstration centers worldwide. Located at Bruker’s headquarters in Billerica, the new center features dedicated lab space for showcasing the latest preclinical imaging technologies and multimodal platforms, together with tissue culture and in vivo subject handling capabilities.

Utilizing Bruker’s preclinical instruments for demonstration and applications development in a single site, visiting customers and Bruker scientists will be able to offer unparalleled levels of support and training, and provide access to new combinations of imaging modalities.

Multiple modalities such as optical imaging and X-ray, or PET and MRI enable researchers to acquire complementary image information, e.g. on morphology and function, which is vital in the further development of medical sciences and translational research.

“The Bruker Preclinical Imaging division is committed to providing cutting-edge tools and we are excited about our ability to combine multiple modalities in one lab to help facilitate new insights for the imaging research community,” commented Dr. Wulf Jung, President of Bruker BioSpin’s Preclinical Imaging division.

The new PCI Center provides access to MRI instruments including a 7 Tesla BioSpec® MRI system with a unique MRI CryoProbe™, and an ICON™ compact, benchtop MRI system. Micro computed X-ray tomography (µCT) is covered by several models, including the in vivo Skyscan™ 1176 and in vitro Skyscan 1272.

The PCI lab also features four optical molecular imaging systems for fluorescence, luminescence, planar x-ray and planar radio-isotopic imaging experiments, with two in vivo Xtreme™ optical systems and two MS FX PRO™ optical imaging systems. The lab benefits from a new electron paramagnetic resonance imaging (EPRI) system, and a minispec™ system for body composition analysis.

A crucial component of employing multi-modality imaging in most research environments is having a comprehensive suite of imaging technologies that include reliable co-registration devices. Bruker’s multimodal animal beds enable flexible and versatile analyses of various animal models based on an easy and productive workflow.

On the Bruker Billerica campus, several MALDI mass spectrometry imaging systems are accessible for in vitro small molecule, lipids or peptide/protein spectroscopic imaging. Additionally, a Bruker Albira II PET/SPECT/CT preclinical imaging system is located nearby at Boston Children’s Hospital, with access to PET and SPECT isotopes.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bruker Announces Acquisition of Prairie Technologies
Acquisition strengthens Bruker Nano Surfaces Division's position in life science markets.
Friday, September 13, 2013
Bruker and ImaBiotech Announces Collaboration
Bruker to distribute ImaBiotech's Quantinetix software for quantitative MALDI imaging.
Friday, June 21, 2013
Bruker to Acquire Carestream’s Preclinical In-vivo Imaging Business
Transaction positions in-vivo products for long-term growth.
Monday, September 24, 2012
Scientific News
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
Have Your Drug Nano-Delivered Via Microbubble
A UC engineering professor is working to develop effective nanoparticle-bubble drug delivery systems to access precise locations in the body to treat medical conditions such as cancer, eye disease and spinal disc degeneration.
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Tension Helps Heart Cells Develop Normally in the Lab
Stanford engineers have uncovered the important role tension plays in growing heart cells out of the body.
Controlling Body Temperature in Response to 'Fight or Flight'
New research in The FASEB Journal suggests that blocking TRPV1 protein causes an increased release of noradrenaline, leading to an increase in core body temperatures.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos